A randomized trial of intraarterial treatment for acute ischemic stroke

New England Journal of Medicine

Volumn 372, Issue 1, 2015, Pages 11-20

  Berkhemer, O A ^a,e   Fransen, P S S ^e   Beumer, D ^e   Van Den Berg, L A ^e   Lingsma, H F ^e   Yoo, A J ^v   Schonewille, W J ^v   Vos, J A ^a   Nederkoorn, P J ^a   Wermer, M J H ^g   Van Walderveen, M A A ⁱ   Staals, J ^a   Hofmeijer, J ^a   Van Oostayen, J A ^h,j   Lycklama Nijeholt, G J ^k   Boiten, J ^a   Brouwer, P A ^e   Emmer, B J ^e   De Bruijn, S F ^a   Van Dijk, L C ^l   Kappelle, L J ^g   Lo, R H ^m   Van Dijk, E J ^g   De Vries, J ^a   De Kort, P L M ^g   Van Rooij, W J J ^a   Van Den Berg, J S P ^g   Van Hasselt, B A A M ^p   Aerden, L A M ^a,g   Dallinga, R J ^b   Visser, M C ^b   Bot, J C J ^b,c   Vroomen, P C ^g,r   Eshghi, O ^c   Schreuder, T H C M L ^b   Heijboer, R J J ^g   Keizer, K ^d   Tielbeek, A V ^g,t   Den Hertog, H M ^g   Gerrits, D G ^u   Van Den Berg Vos, R M ^d   Karas, G B ^d   Steyerberg, E W ^e   Flach, H Z ^p   Marquering, H A ^a   Sprengers, M E S ^a   Jenniskens, S F M ^b,g,n   Beenen, L F M ^a   Van Den Berg, R ^a   Koudstaal, P J ^a,e   Van Zwam, W H ^f   Roos, Y B W E M ^a   Van Der Lugt, A ^f   Van Oostenbrugge, R J ^f,q,s   Majoie, C B L M ^a   Dippel, D W J ^e,g,o   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Department of Neurology ^*

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g Departments of Neurology   (Netherlands)

^h ST ANTONIUS HOSPITAL   (Netherlands)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j RIJNSTATE HOSPITAL   (Netherlands)

^k Onze Lieve Vrouwe Gasthuis   (Netherlands)

^l HAGA HOSPITAL   (Netherlands)

^m UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁿ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^o CPRLab   (Netherlands)

^p ISALA HOSPITAL   (Netherlands)

^q REINIER DE GRAAF HOSPITAL   (Netherlands)

^r UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^s Sittard Geleen Heerlen   (Netherlands)

^t CATHARINA HOSPITAL   (Netherlands)

^u MEDISCH SPECTRUM TWENTE   (Netherlands)

^v MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; UROKINASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ADVERSE OUTCOME; AGED; ALLERGIC REACTION; ARTERY CATHETERIZATION; ARTICLE; BARTHEL INDEX; BLOOD CLOT LYSIS; BLOOD CLOT RETRACTION; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CAROTID ARTERY STENTING; CEREBRAL REVASCULARIZATION; CLINICAL EFFECTIVENESS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EMBOLECTOMY SYSTEM; EMERGENCY TREATMENT; FEMALE; FUNCTIONAL STATUS; HEART MUSCLE ISCHEMIA; HUMAN; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; INTRAARTERIAL DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MICROCATHETER; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PATIENT SAFETY; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PROGNOSIS; QUALITY OF LIFE; QUALITY OF LIFE INDEX; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; REPERFUSION; SCORING SYSTEM; SELF REPORT; SUBARACHNOID HEMORRHAGE; SYMPTOMATOLOGY; THROMBOEMBOLISM; THROMBUS ASPIRATION; VERY ELDERLY; ACUTE DISEASE; CATHETERIZATION; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RISK; SINGLE BLIND PROCEDURE; STATISTICAL MODEL; STROKE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CATHETERIZATION; COMBINED MODALITY THERAPY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LOGISTIC MODELS; MALE; MECHANICAL THROMBOLYSIS; MIDDLE AGED; ODDS RATIO; SINGLE-BLIND METHOD; STROKE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84920502575     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1411587     Document Type: Article

References (34)

1. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 August 5 (Epub ahead of print).
2. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.
3. Beumer D, Saiedie G, Fonvile S, et al. Intra-arterial occlusion in acute ischemic stroke: relative frequency in an unselected population. Cerebrovasc Dis 2013;35:Suppl: 66.
4. Heldner MR, Zubler C, Mattle HP, et al. National Institutes of Health Stroke Scale score and vessel occlusion in 2152 patients with acute ischemic stroke. Stroke 2013; 44:1153-7.
5. Christou I, Burgin WS, Alexandrov AV, Grotta JC. Arterial status after intravenous TPA therapy for ischaemic stroke: a need for further interventions. Int Angiol 2001;20:208-13.
6. Lima FO, Furie KL, Silva GS, et al. Prognosis of untreated strokes due to anterior circulation proximal intracranial arterial occlusions detected by use of computed tomography angiography. JAMA Neurol 2014;71:151-7.
7. Lee M, Hong KS, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ische-mic stroke: meta-analysis of randomized controlled trials. Stroke 2010;41:932-7.
8. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombi-nant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11.
9. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke-the PROACT II study: a randomized controlled trial. JAMA 1999; 282:2003-11.
10. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007; 38:2633-9.
11. Mehta B, Leslie-Mazwi TM, Chandra RV, et al. Assessing variability in neuroin-terventional practice patterns for acute ischemic stroke. J Neurointerv Surg 2013;5: Suppl 1:i52-i57.
12. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893-903.
13. Erratum, N Engl J Med 2013;368:1265.
14. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368: 904-13.
15. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovas-cular treatment for ischemic stroke. N Engl J Med 2013;368:914-23.
16. Fransen PS, Beumer D, Berkhemer OA, et al. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials 2014;15: 343.
17. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interob-server agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-7.
18. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208.
19. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965;14:61-5.
20. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000;355:1670-4.
21. Erratum, Lancet 2000;355:2170.
22. Khatri P, Neff J, Broderick JP, Khoury JC, Carrozzella J, Tomsick T. Revascular-ization end points in stroke intervention-al trials: recanalization versus reperfu-sion in IMS-I. Stroke 2005;36:2400-3.
23. Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascu-larization grading standards for acute ischemic stroke: a consensus statement. Stroke 2013;44:2650-63.
24. Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999;30:2280-4.
25. Boers AM, Marquering HA, Jochem JJ, et al. Automated cerebral infarct volume measurement in follow-up noncontrast CT scans of patients with acute ischemic stroke. AJNR Am J Neuroradiol 2013;34: 1522-7.
26. Saver JL. Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials. Stroke 2007;38:3055-62.
27. Hernández AV, Steyerberg EW, Habbema JD. Covariate adjustment in randomized controlled trials with dichot-omous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol 2004;57:454-60.
28. Whitehead J. Sample size calculations for ordered categorical data. Stat Med 1993;12:2257-71.
29. Erratum, Stat Med 1994; 13:871.
30. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for throm-bectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380:1231-40.
31. Erratum, Lancet 2012; 380:1230.
32. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci retriever in patients with acute is-chaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-9.
33. Dorn F, Stehle S, Lockau H, Zimmer C, Liebig T. Endovascular treatment of acute intracerebral artery occlusions with the solitaire stent: single-centre experience with 108 recanalization procedures. Cerebrovasc Dis 2012;34:70-7.
34. Pereira VM, Gralla J, Davalos A, et al. Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke. Stroke 2013;44:2802-7.